Journal
JOURNAL OF TISSUE ENGINEERING
Volume 5, Issue -, Pages -Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/2041731414551764
Keywords
Cell; and tissue-based therapy; translational medical research; regenerative medicine; tissue engineering; stem cells
Categories
Funding
- National Institutes of Health [HL095722]
- Department of Defense [W81XWH-13-1-0305]
- Movember-Prostate Cancer Foundation Challenge Award
Ask authors/readers for more resources
There has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this magnitude of activity. We hypothesize that the paucity of engagement with the clinical community is a key contributor to the lack of commercially successful cell therapy products. To investigate this, we launched a pilot study to survey clinicians from five specialities and to determine what they believe to be the most significant barriers to cellular therapy clinical development and adoption. Our study shows that the main concerns among this group are cost-effectiveness, efficacy, reimbursement, and regulation. Addressing these concerns can best be achieved by ensuring that future clinical trials are conducted to adequately answer the questions of both regulators and the broader clinical community.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available